CoLucid Pharmaceuticals Provides SAMURAI Enrollment Update By: Benzinga via Benzinga November 30, 2015 at 08:03 AM EST CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD) today announced that over 50% of the migraine patients needed to complete the Company's ... Read More >>